Enzon Pharmaceuticals, Inc. (ENZN)

S&P 500: 890.35
Change: -2.13%

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

Avatar JonAtkins57 (< 20) Submitted: 6/27/08 12:26 PM : Start Price: $7.47 ENZN Score: 9.59

Market Cap >100M and <1B
P/E Ratio < 10
Div Yield < 1%
52w % Change < 20%
Net Profit Margin % > 20
Gross Margin % > 20
Current Ratio > 1
EPS > 0

Featured Broker Partners